Cellares: Revolutionizing cell therapy manufacturing

Cellares is tackling one of biotech's most urgent bottlenecks: scaling life-saving cell therapies from artisanal production to industrial manufacturing. Headquartered in San Francisco with a Chicago presence at TeamWorking by TechNexus, the company was born from a vision to fix the constraints that keep cell therapies from reaching more patients.

In the fast-evolving world of biotech, Cellares stands out for tackling one of the industry’s most urgent problems: scaling life-saving cell therapies. Headquartered in San Francisco with a Chicago office located at TeamWorking by TechNexus, Cellares was born from the vision to fix the bottlenecks in manufacturing. And in doing so, Cellares has grown into a global cell therapy innovator. The inspiration for Cellares came from a simple, but profound gap: while cell therapies like CAR-T showed tremendous promise, their production was slow, manual, and costly. Patients eligible for these treatments often faced long waitlists, with an estimated 20% dying before receiving therapy. Backed by $355 million in total funding, the company set out to solve this bottleneck with a bold new approach to manufacturing. Cellares’ solution? Rethink manufacturing itself. The company introduced the concept of an Integrated Development and Manufacturing Organization (IDMO)—a new category that moves beyond the traditional CDMO (Contract Development and Manufacturing Organization) model. Through proprietary technologies like the Cell Shuttle and Cell Q, Cellares is making it possible to manufacture ten times as many doses within the same footprint, at up to 50% lower batch costs. The company’s smart factories, including facilities under construction in New Jersey, Europe, and Japan, represent a future where waitlists disappear, costs drop, and life-saving therapies reach more patients worldwide. Growing with Global Reach, and Chicago Roots Since its founding, Cellares has expanded rapidly. With a headquarters and R&D center in South San Francisco, the company also established a strong presence in Chicago—growing its software engineering team from a handful to over a dozen. Chicago plays a critical role in Cellares’ technology evolution. Here, engineers focus on building the software systems that control and monitor the Cell Shuttle’s manufacturing processes. By shifting manufacturing v

By Jim Dallke at TechNexus Venture Collaborative